Clinical Domain Working Groups
Myeloid Malignancy Variant Curation Expert Panel
Membership DocumentsThe Myeloid Malignancy Variant Curation Expert Panel (MM-VCEP) curates variants in genes associated with inherited risk for myeloid malignancies. Our panel considers variants in genes that cause life-long thrombocytopenia (e.g., RUNX1, ANKRD26, and ETV6) as well as those associated only with cancer risk (e.g., GATA2, DDX41 and CEBPA). The MM-VCEP has collaborated with ASH, and is currently supported by the National Cancer Institute. We aim to encourage standardized variant curation, which will improve variant reporting and facilitate optimal treatment of patients and their families.
Expert Panel Status
Documents
-
Myeloid Malignancy Variant Curation Expert Panel COIConflict Of Interest (COI) - September 1, 2022
-
ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2Curation Activity Procedures - September 14, 2021 Archived Document
-
-
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variantsPublications - October 22, 2019
-
ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1Curation Activity Procedures - July 10, 2019 Archived Document
Expert Panel Membership
Membership spans many fields, including genetics, medical, academia, and industry.
Leadership
Coordinators
Curators
Members
Past Members
Chairs
Coordinators
Please contact a coordinator if you have questions.
In partnership with:
Visit the ClinGen Partnership Working Group page to learn about the nature of ClinGen's funding agreements with partners.